Oura, the Finnish maker of the hugely popular health tracking rings, raised $900 million in Series E funding at an $11 billion valuation led by Fidelity Management & Research, the company announced on Tuesday.
That’s more than double its $5 billion valuation from when it raised its Series D round last November, underscoring the appeal of personalized health companies to VCs. The category has exploded in the last few years as companies like Apple, Garmin, Whoop and Oura have developed products with increasingly sophisticated tracking capabilities.
Oura owes much of its success to its sleek ring with an understated appearance rather than a watch or wristband like its competitors’ products. The company, which is profitable, has sold more than 2.75 million of its 5.5 million total sold rings in the last year, and it expects to surpass $1 billion in annual sales by the end of the year.
Its rings have also become dual-use: Its biggest enterprise customer is the US Department of Defense. Beginning in 2019 with the Naval Health Research Center, the business relationship has since grown to all branches of US armed services. The company is also building a manufacturing facility in Fort Worth, specifically for DoD contracts.
As a category, direct-to-consumer wearables are fickle, as they largely depend on consumer tastes and fashion trends. FitBit, a fitness tracker so popular at one time that Google acquired it in 2021, has since faded.
Although Oura’s absolute ring sales are not on par with Garmin’s watch sales, the ring company is currently growing faster, at a rate of more than 100%. Garmin’s fitness category grew 41% for the year ending June 2025, according to its most recent earnings results.
Featured image courtesy of Oura
Learn about our editorial standards.